BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3174 related articles for article (PubMed ID: 26980491)

  • 21. Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China.
    Luo D; Chen Q; Xiong G; Peng Y; Liu T; Chen X; Zeng L; Chen K
    Sci Rep; 2019 May; 9(1):7315. PubMed ID: 31086215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in molecular epidemiology of drug-resistant tuberculosis in Republic of Karelia, Russian Federation.
    Mokrousov I; Vyazovaya A; Solovieva N; Sunchalina T; Markelov Y; Chernyaeva E; Melnikova N; Dogonadze M; Starkova D; Vasilieva N; Gerasimova A; Kononenko Y; Zhuravlev V; Narvskaya O
    BMC Microbiol; 2015 Dec; 15():279. PubMed ID: 26679959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major genotype families and epidemic clones of Mycobacterium tuberculosis in Omsk region, Western Siberia, Russia, marked by a high burden of tuberculosis-HIV coinfection.
    Pasechnik O; Vyazovaya A; Vitriv S; Tatarintseva M; Blokh A; Stasenko V; Mokrousov I
    Tuberculosis (Edinb); 2018 Jan; 108():163-168. PubMed ID: 29523319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 24 loci MIRU-VNTR analysis and pattern of drug resistance in pre-extensively drug resistant pulmonary tuberculosis in Bangladesh.
    Monir BB; Sultana SS; Tarafder S
    Infect Genet Evol; 2022 Aug; 102():105304. PubMed ID: 35595025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].
    Wang JJ; Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1189-93. PubMed ID: 20193593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First insights into the genetic characteristics and drug resistance of Mycobacterium tuberculosis population collected during the first national tuberculosis prevalence survey of Lao PDR (2010-2011).
    Somphavong S; Berland JL; Gauthier M; Vu TT; Nguyen QH; Iem V; Vongvichit P; Inthavong D; Akkhavong V; Chanthavilay P; Soundala S; Keovichit I; Paranhos-Baccalà G; Paboriboune P; Nguyen TVA; Bañuls AL
    BMC Infect Dis; 2019 Oct; 19(1):851. PubMed ID: 31615439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China.
    Li Q; Wang Y; Li Y; Gao H; Zhang Z; Feng F; Dai E
    J Glob Antimicrob Resist; 2019 Sep; 18():168-176. PubMed ID: 30926465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the genetic diversity of extensively-drug resistant Mycobacterium tuberculosis clinical isolates from pulmonary tuberculosis patients in Peru.
    Cáceres O; Rastogi N; Bartra C; Couvin D; Galarza M; Asencios L; Mendoza-Ticona A
    PLoS One; 2014; 9(12):e112789. PubMed ID: 25489950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of
    Elegail A; Ibrahim Mohamed NY; Mohamed Nour EO; Hoffner S; Haile M
    Int J Mycobacteriol; 2018; 7(3):236-241. PubMed ID: 30198502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
    Singhal P; Dixit P; Singh P; Jaiswal I; Singh M; Jain A
    Indian J Med Res; 2016 Mar; 143(3):341-7. PubMed ID: 27241648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of Mycobacterium tuberculosis strains.
    Li QJ; Jiao WW; Yin QQ; Li YJ; Li JQ; Xu F; Sun L; Xiao J; Qi H; Wang T; Mokrousov I; Huang HR; Shen AD
    Int J Antimicrob Agents; 2017 Jun; 49(6):757-762. PubMed ID: 28456705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human multidrug-resistant Mycobacterium bovis infection in Mexico.
    Vazquez-Chacon CA; Martínez-Guarneros A; Couvin D; González-Y-Merchand JA; Rivera-Gutierrez S; Escobar-Gutierrez A; De-la-Cruz López JJ; Gomez-Bustamante A; Gonzalez-Macal GA; Gonçalves Rossi LM; Muñiz-Salazar R; Rastogi N; Vaughan G
    Tuberculosis (Edinb); 2015 Dec; 95(6):802-809. PubMed ID: 26299906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus.
    Wollenberg KR; Desjardins CA; Zalutskaya A; Slodovnikova V; Oler AJ; Quiñones M; Abeel T; Chapman SB; Tartakovsky M; Gabrielian A; Hoffner S; Skrahin A; Birren BW; Rosenthal A; Skrahina A; Earl AM
    J Clin Microbiol; 2017 Feb; 55(2):457-469. PubMed ID: 27903602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
    Said HM; Kock MM; Ismail NA; Mphahlele M; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    J Clin Microbiol; 2012 Sep; 50(9):2857-62. PubMed ID: 22649019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spoligotyping of Mycobacterium tuberculosis isolates at a tertiary care hospital in India.
    Suzana S; Shanmugam S; Uma Devi KR; Swarna Latha PN; Michael JS
    Trop Med Int Health; 2017 Jun; 22(6):703-707. PubMed ID: 28374900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
    Yenew B; Kebede A; Alemu A; Diriba G; Mehammed Z; Amare M; Dagne B; Sinshaw W; Tesfaye E; Beyene D; Abegaz WE
    PLoS One; 2024; 19(5):e0303460. PubMed ID: 38753615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective.
    Perdigão J; Macedo R; João I; Fernandes E; Brum L; Portugal I
    Microb Drug Resist; 2008 Jun; 14(2):133-43. PubMed ID: 18573039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.
    Yin QQ; Jiao WW; Li QJ; Xu F; Li JQ; Sun L; Li YJ; Huang HR; Shen AD
    BMC Microbiol; 2016 May; 16():85. PubMed ID: 27176471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
    BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study.
    Hu Y; Hoffner S; Jiang W; Wang W; Xu B
    BMC Infect Dis; 2010 Feb; 10():43. PubMed ID: 20187977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 159.